[1] 宋红梅.EB病毒相关的淋巴增生性疾病的诊断与治疗[J]. 实用儿科临床杂志, 2008, 23(21):1641-1644.
[2] Coghill A E, Hildesheim A. Epstein-Barr Virus Antibodies and the Risk of Associated Malignancies: Review of the Literature [J].Am J Epidemiol, 2014, 180(7):687-695.
[3] Luzuriaga K, Sullivan J L. Infectious mononucleosis[J]. N Engl J Med, 2010, 362(21):1993-2000.
[4] 胡亚美,江载芳,申昆玲,等. 诸福棠实用儿科学[M]. 8版. 北京:人民卫生出版社,2015:916-919.
[5] 李 辉,曹 斌. 急慢性EB病毒感染特点及预后影响因素[J].中国实用内科杂志,2014,34(11):1116-1118.
[6] Evridiki K V, Petros I R, Matthew E F. Current diagnosis and management of infectious mononucleosis [J]. Curr Opin Hematol, 2012, 19(1):14–20.
[7] Maakaroun N R, Moanna A, Jacob J T, et al. Viral infections associated with haemophagocytic syndrome[J]. Rev Med Virol ,2010, 20(2):93–105.
[8] 黄 璨,吕 玮.成人慢性活动性EB病毒感染3例并文献复习[J]. 中国临床医生, 2014, 42(3):38-41.
[9] Arai A, Imadome K, watanabe Y, et al. Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis [J]. Int J Hematol, 2011, 93(5):602-609.
[10] Cohen J I , Jaffe E S, Dale J K, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States [J]. Blood, 2011, 117(22): 5835-5849.
[11] 宋红梅,梅吴晓,燕 王,等.严重慢性活动性EB病毒感染12例临床回顾与随访[J].中华儿科杂志, 2009, 47(9):682-686.
[12] 邢 燕,宋红梅,李太生,等.慢性活动性EB病毒感染外周血淋巴细胞免疫亚群变化特征的研究[J]. 中华儿科杂志, 2009, 47(6) : 441-445.
[13] 邢 燕,宋红梅,吴晓燕,等.慢性活动性EB 病毒感染患儿外周血单个核细胞EB 病毒DNA 及感染细胞类型检测的临床意义[J]. 中华儿科杂志, 2011, 49(7):495-500.
[14] Straus S E. The chronic mononucleosis syndrome[J]. J Infect Dis, 1988, 157(3): 405-412.
[15] 段红梅,申昆玲.慢性活动性EB病毒感染的诊断标准和治疗[J]. 实用儿科临床杂志, 2006, 21(10): 638-640.
[16] Ohga S, Sanefuji M, Ishimura M, et al. Epstein-Barr virus load in cerebrospinal fluid of patients with chronic active Epstein-Barr virus infection[J]. Pediatr Infect Dis J, 2008, 27(11):1027-1030.
[17] 贾国存,刘 炜,毛彦娜,等.噬血性淋巴组织细胞增生症20例[J].实用儿科临床杂志,2011, 26(3): 191-195.
[18] 万 智,袁粒星,刘晓丽,等.噬血性淋巴组织细胞增生症患儿血清生长分化因子15水平检测及意义[J].中华实用儿科临床杂志,2013, 28(3):168-171.
[19] 胡亚美,江载芳,申昆玲,等. 诸福棠实用儿科学[M]. 8版. 北京:人民卫生出版社,2015:1939-1945.
[20] Imashuku S. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010 [J]. J Pediatr Hematol Onco1, 2011, 33(1):35-39.
[21] Szyper-Kravitz M. The hemophagocytic syndrome/Macrophageactivation Syndrome: A finalcommon pathway of a cytokine storm[J].IMAJ, 2009,1l(10):633-634.
[22] Zhizhuo H, Junmei X, Yuelin S, et al. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer,2012, 58(3):410-414.
[23] Lee W I, Chen S H, Hung U, et a1.Clinical aspects,immunologic assessment, and genetic analysis in Taiwanese children with hemophagocytic lymphohistiocytosis[J]. Pediatr Infect Dis J, 2009, 28(1):30-34.
[24] Henter J I, Home A, Arico M, et al.HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2007, 48(2):124-131.
[25] 吴润辉, 马晓莉.儿童噬血细胞性淋巴组织细胞增生症的诊断标准[J]. 实用儿科临床杂志, 2009, 8(15):1211-1213.
[26] Freeman H R, Raman A V. Review of haemophagocytic lymphohistiocytosis [J].Arch Dis Child, 2011, 96(7):688-693.
[27] 黄志卓,谢正德,闫 静,等.EB病毒相关细胞性淋巴组织细胞增生症患儿的EB病毒感染特征[J]. 实用儿科临床杂志, 2012, 27(3):181-183.
[28] 李彦珊,刘秋玲,袁海莲,等. 儿童噬血细胞综合征2例[J]. 武警医学院学报, 2010, 19(12):1020-1021.
[29] Jin Y K, Xie Z D, Yang S, et al.Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: A retrospective study of 78 pediatric cases in mainland of China[J]. Chin Med J (Engl), 2010, 123(11):1426-1430.
[30] 胡亚美,江载芳,申昆玲,等. 诸福棠实用儿科学[M]. 8版. 北京:人民卫生出版社,2015:2376-2392.
[31] Barros M H, Vera-Lozada G, Soares F A, et al. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection[J]. Int J Cancer, 2012, 131(5):1142-1152.
[32] Hjalgrim H. On the aetiology of Hodgkin lymphoma[J]. Dan Med J, 2012, 59(7):B4485.
[33] Di Napoli A, Al-Jadiri M F, Talerico C, et al. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Stern?berg cells [J]. Pediatr Blood Cancer, 2013, 60(12):2068-2072.
[34] Huang X, Hepkema B, Nolte I, et al. HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China [J]. PLoS One,2012, 7(2): e31865.
[35] Kushekhar K, van den Berg A, Nolte I, et al. Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms [J]. Cancer Epidemiol Biomarkers Prev,2014, 23(12):2737-2747.
[36] Chung H J, Park C J, Lim J H, et al. Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis [J]. Int J Lab Hematol, 2010, 32(2):239-247.
[37] Li Y X,Yao B,Jin J,et al.Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma[J].J Clin Oncol,2006,24(1):181-189.
[38] 平凌燕,丁 宁,时云飞,等. EBV感染后LMP-1阳性霍奇金淋巴瘤患者临床特点及预后分析[J]. 中国实验血液学杂志,2014,22(1):78-84.
[39] 赵利容,罗泊涛,陈小毅. EB 病毒编码的潜伏膜蛋白2A 在鼻咽癌中的研究进展[J].山东医药,2013,53(28):102-104.
[40] Amandine G B, Florence S, Anne P, et al. Acute acalculous cholecystitis, a rare complication of Epstein-Barr virus primary infection: Report of two cases and review [J]. Journal of Clinical Virology, 2014, 61(1):173-175.